Commentary on “Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: A retrospective analysis with independent validation.” Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.-Reference-Cited by-同舟云学术

Commentary on “Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: A retrospective analysis with independent validation.” Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX.

Published:2014-08 Issue:6 Volume:32 Page:934-935
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Boorjian Stephen

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference2 articles.

1. BAP1 loss defines a new class of renal cell carcinoma;Peña-Llopis;Nat Genet,2012

2. Limitations of Preoperative Biopsy in Patients With Metastatic Renal Cell Carcinoma: Comparison to Surgical Pathology in 405 Cases;Abel;BJU Int,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Label-Free SERS of Urine Components: A Powerful Tool for Discriminating Renal Cell Carcinoma through Multivariate Analysis and Machine Learning Techniques;International Journal of Molecular Sciences;2024-03-31

2. CENPW as a biological indicator: predicting prognosis and guiding treatment in a patient with Kidney Renal Clear Cell Carcinoma;2023-03-07

3. Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma;Frontiers in Microbiology;2022-07-04

4. The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma;Tumor Biology;2017-05